This opportunity involves using the Olink Explore HT platform to analyze proteomic changes in bone marrow plasma from patients with Myelodysplastic Syndromes, building on preliminary data to identify disease biology and therapeutic targets. The work is funded by a Bench to Bedding grant, though no specific budget amount is provided. Performance location is not specified. No non-bid or submission timelines are mentioned. The proprietary Olink platform is required, as third-party alternatives may not deliver the necessary analysis or comparability.